{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:52:38Z","timestamp":1787953958887,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005860","name":"Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.amjcard.2025.05.012","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T02:29:16Z","timestamp":1747189756000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hemodynamic Response to Exercise and Quality of Life in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction"],"prefix":"10.1016","volume":"251","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1715-1329","authenticated-orcid":false,"given":"Helga Lillian","family":"Gudmundsdottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Axelsson","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Rasmusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Snoer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Juel","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H\u00f8rby","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Bundgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Jakob","family":"Thune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amjcard.2025.05.012_bib0001","first-page":"376","article-title":"Global burden of hypertrophic cardiomyopathy","volume":"6","author":"Maron","year":"2018","journal-title":"JACC: Heart Failure"},{"issue":"4","key":"10.1016\/j.amjcard.2025.05.012_bib0002","article-title":"Lifetime clinical course of hypertrophic cardiomyopathy","volume":"2","author":"Maurizi","year":"2023","journal-title":"JACC: Adv"},{"issue":"11","key":"10.1016\/j.amjcard.2025.05.012_bib0003","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrcardio.2016.140","article-title":"Update on hypertrophic cardiomyopathy and a guide to the guidelines","volume":"13","author":"Sen-Chowdhry","year":"2016","journal-title":"Nature Rev Cardiol"},{"issue":"5","key":"10.1016\/j.amjcard.2025.05.012_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006657","article-title":"Clinical outcomes in patients with nonobstructive, labile, and obstructive hypertrophic cardiomyopathy","volume":"7","author":"Lu","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2025.05.012_bib0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12955-020-01604-9","article-title":"Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire","volume":"18","author":"Capota","year":"2020","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1016\/j.amjcard.2025.05.012_bib0006","first-page":"ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.amjcard.2025.05.012_bib0007","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/ehf2.14345","article-title":"Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care","volume":"10","author":"Garmany","year":"2023","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.amjcard.2025.05.012_bib0008","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12955-016-0467-x","article-title":"Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators","volume":"14","author":"Magnusson","year":"2016","journal-title":"Health Quality Life Outcomes"},{"issue":"1","key":"10.1016\/j.amjcard.2025.05.012_bib0009","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.genhosppsych.2007.09.005","article-title":"Psychiatric disorders in hypertrophic cardiomyopathy","volume":"30","author":"Morgan","year":"2008","journal-title":"General Hospital Psychiatry"},{"issue":"3","key":"10.1016\/j.amjcard.2025.05.012_bib0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11136-012-0182-y","article-title":"Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy","volume":"22","author":"Huff","year":"2013","journal-title":"Quality Life Res"},{"issue":"2","key":"10.1016\/j.amjcard.2025.05.012_bib0011","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/hrt.78.2.182","article-title":"Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy","volume":"78","author":"Cox","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2025.05.012_bib0012","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s41687-020-00269-8","article-title":"Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life","volume":"4","author":"Zaiser","year":"2020","journal-title":"J Patient-Rep Outcomes"},{"key":"10.1016\/j.amjcard.2025.05.012_bib0013","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.124.070064","article-title":"Exercise training in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction: a randomized clinical trial","volume":"151","author":"Gudmundsdottir","year":"2024","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.amjcard.2025.05.012_bib0014","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.2017.2503","article-title":"Effect of Moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: a randomized clinical trial","volume":"317","author":"Saberi","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.amjcard.2025.05.012_bib0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jjcc.2019.04.013","article-title":"Efficacy and safety of exercise rehabilitation in patients with hypertrophic cardiomyopathy","volume":"74","author":"Wasserstrum","year":"2019","journal-title":"J Cardiol"},{"issue":"1","key":"10.1016\/j.amjcard.2025.05.012_bib0016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2047487313501277","article-title":"Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center","volume":"22","author":"Klempfner","year":"2015","journal-title":"Eur J Prevent Cardiol"},{"issue":"8","key":"10.1016\/j.amjcard.2025.05.012_bib0017","first-page":"531","article-title":"Validation of the Kansas City Cardiomyopathy Questionnaire in symptomatic obstructive hypertrophic cardiomyopathy","volume":"10","author":"Nassif","year":"2022","journal-title":"JACC: Heart Failure"},{"issue":"5","key":"10.1016\/j.amjcard.2025.05.012_bib0018","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ejhf.2481","article-title":"Defining changes in physical limitation from the patient perspective: insights from the VITALITY-HFpEF randomized trial","volume":"24","author":"Butler","year":"2022","journal-title":"Eur J Heart Failure"},{"issue":"7","key":"10.1016\/j.amjcard.2025.05.012_bib0019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11886-021-01511-5","article-title":"Patient-reported outcomes in patients with cardiomyopathy","volume":"23","author":"Garcia","year":"2021","journal-title":"Curr Cardiol Rep"},{"issue":"20","key":"10.1016\/j.amjcard.2025.05.012_bib0020","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care","volume":"76","author":"Spertus","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.amjcard.2025.05.012_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0587.2012.07348.x","article-title":"Collinearity: a review of methods to deal with it and a simulation study evaluating their performance","volume":"36","author":"Dormann","year":"2013","journal-title":"Ecography"},{"issue":"9","key":"10.1016\/j.amjcard.2025.05.012_bib0022","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1590\/1414-431X20132902","article-title":"Diastolic function is associated with quality of life and exercise capacity in stable heart failure patients with reduced ejection fraction","volume":"46","author":"Bussoni","year":"2013","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"10.1016\/j.amjcard.2025.05.012_bib0023","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ahj.2011.01.003","article-title":"Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters: quality of life in diastolic dysfunction","volume":"161","author":"Edelmann","year":"2011","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.amjcard.2025.05.012_bib0024","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ehjci\/jeaa253","article-title":"Diastolic dysfunction and mortality in 436\u2009360 men and women: the National Echo Database Australia (NEDA)","volume":"22","author":"Playford","year":"2021","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"25","key":"10.1016\/j.amjcard.2025.05.012_bib0025","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","article-title":"Randomized trial of metoprolol in patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Dybro","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.amjcard.2025.05.012_bib0026","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamacardio.2023.3342","article-title":"Mavacamten in patients with hypertrophic cardiomyopathy referred for septal reduction: week 56 results from the VALOR-HCM randomized clinical trial","volume":"8","author":"Desai","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.amjcard.2025.05.012_bib0027","article-title":"Quality of life and exercise capacity in early stage and subclinical hypertrophic cardiomyopathy: a secondary analysis of the VANISH trial","volume":"17","author":"Ireland","year":"2024","journal-title":"Circulation: Heart Failure"},{"key":"10.1016\/j.amjcard.2025.05.012_bib0028","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2350-11-27","article-title":"Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population","volume":"11","author":"Hamang","year":"2010","journal-title":"BMC Med Genet"},{"issue":"10293","key":"10.1016\/j.amjcard.2025.05.012_bib0029","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/S0140-6736(21)00763-7","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"397","author":"Spertus","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2025.05.012_bib0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pcad.2023.08.007","article-title":"Patient-reported outcomes in clinical studies of patients with hypertrophic cardiomyopathy","volume":"80","author":"Reza","year":"2023","journal-title":"Prog Cardiovasc Dis"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925003121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925003121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:35:25Z","timestamp":1755693325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914925003121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"alternative-id":["S0002914925003121"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.05.012","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemodynamic Response to Exercise and Quality of Life in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}